References
1. Tsimihodimos V, Bairaktari E, Tzallas C, Miltiadus G, Liberopoulos E, Elisaf M. Incidence of thyroid function abnormal-lities in patients attending an outpatient lipid clinic. Thyroid 1999; 9:365-8.
2. Stone NJ. Secondary causes of hyperlipidemia. Med Clin North Am 1994; 78:117-41.
3. Bakker O, Hudig F, Meijssen S, Wiersinga WM. Effects of T3 and amiodarone on promoter of human LDL receptor gene. Biochem Biophys Res Commun 1998; 249:517-21.
4. Shin DJ, Osborne TF. Thyroid hormone regulation and cholesterol metabolism are connected through SREBP-2. J Biol Chem 2003; 278:34114-8.
5. Walton KW, Scott PJ, Dykes PW, Davies JW. The significance of alterations in serum lipids in thyroid dysfunction. Clin Sci 1965; 29:217-38.
6. Thompson GR, Soutar AK, Spengel FA, Jadhav A, Gavigan SJ, Myant NB. Defects of receptor mediated LDL catabolism in hypercholesterolemia and hypothyroidism. Proc Natl Acad Sci USA 1981; 78:2591-5.
7. Abrams JJ, Grundy SM. Cholesterol metabolism in hypothyroidism and hyperthyroidism in man. J Lipid Res 1981; 22:323-38.
8. Lagrost L. Regulation of CETP activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1994; 1215:209-36.
9. Kuusi T, Saarinen P, Nikkila EA. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma HDL-2. Atherosclerosis 1980; 36:589-93.
10. Santamarina FS, Navarro GH, Freeman L, Wagner E, Nong Z. Hepatic lipase, lipoprotein metabolism and atherogenesis. Arterioscler Thromb Vasc Biol 2004; 24:1750-4.
11. Nikkila EA, Kekki M. Plasma triglyceride metabolism in thyroid disease.
J Clin Invest 1972; 51:2103-14.
12. Al-Tonsi A, Abdel AG, Saad M. Secondary dyslipidemia and deranged serum phosphate conc. in thyroid disorders. Exp Mol Pathol 2004; 76:182-7.
13. Teixeira PF, Reuters VS, Ferreira MM. Lipid profile in hypothyroidism and effects of LT4 in mild thyroid failure. Trans Res 2008; 151:224-31.
14. Pearce EN, Wilson PW, Yang Q, Vasan RS, Braverman LE. Thyroid function and lipid subparticle sizes in patients with short term hypothyroidism and a population based cohort. J Clin Endocrinol Metab 2008; 93:888-94.
15. Lam KS, Chan MK, Yeung RT. HDL-cholesterol, hepatic lipase and LPL activities in thyroid dysfunction - effect of treatment. QJ Med 1986; 59:513-21.
16. Lee WY, Suh JY, Rhee EJ, Park JS, Sung KC. Plasma CRP, apoA1, apoB and Lp(a) levels according to thyroid function. Arch Med Res 2004; 35:540-5.
17. Liberopoulos EN, Elisaf MS. Dyslipidemia in patients with thyroid disorders. Hormones 2002; 1(4):218-23.
18. Rizos CV, Elisaf MS and Liberopoulos EN. Effects of thyroid dysfunction on lipid profile. The Open Cardiovascular Medicine Journal 2011; 5:76-84.
19. Hueston WJ, Pearson WS. Subclinical hypothyroidism and the risk of hypercholesterolemia. Am Fam Med 2004; 2:351-5.
20. Sheikh BA, Soomro AA, Soomro MA, Pirzado ZA. Lipid profile in primary hypothyroidism. Medical channel 2009; 15(4):15-8.
21. Efstathiadou Z, Bitsis S, Milionis HJ. Lipid profile in SH: is L-thyroxine substitution beneficial? Eur J Endocrinol 2001; 145:705-10.
22. Costantini F, Pierdomenico SD, Cesare DD. Effect of thyroid function on LDL oxidation. Arterioscler Thromb Vasc Biol 1998; 18:732-7.
23. Adrees M, Gibney J, Saeity N, Boran G. Effects of 18 months of L-T4
replacement in women with SH. J Clin Endocrinol 2009; 71:298-303.
24. Maugeri D, Santangelo A, Barbagallo P, Bonanno MR, Malaguarnera M, Rizza I, Speciale S. Thyroid hormones and lipid metabolism in a group of patients over seventy. Eur Rev Med Pharm Sci 1999; 3:211-6.
25. Prieur X, Huby T, Coste H. Thyroid Hormone Regulates the Hypotriglyceri-demic Gene APOA5. J Biol Chem 2005; 280(30):27533-43.
26. Abrams JJ, Grundy SM, Ginsberg H. Metabolism of plasma triglycerides in hypo and hyperthyroidism. J Lipid Res1981; 22:307-22.
27. Prakash A, Lal AK. Serum lipids in hypothyroidism: our experience. Indian J Clin Biochem 2006; 21(2):153-5.
DOI: https://dx.doi.org/10.18535/jmscr/v5i1.65
